Align Technology Stock Price, News & Analysis (NASDAQ:ALGN)

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Align Technology in the last twelve months. There are currently 3 hold ratings and 7 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" ALGN shares.
View ALGN analyst ratings or view top-rated stocks.

10 Wall Street research analysts have issued 1 year price targets for Align Technology's shares. Their ALGN share price targets range from $200.00 to $450.00. On average, they expect the company's share price to reach $336.60 in the next twelve months. This suggests a possible upside of 55.5% from the stock's current price.
View analysts price targets for ALGN or view top-rated stocks among Wall Street analysts.

Align Technology's stock was trading at $210.90 at the beginning of 2023. Since then, ALGN shares have increased by 2.6% and is now trading at $216.48.
View the best growth stocks for 2023 here.

Align Technology saw a decline in short interest in the month of November. As of November 15th, there was short interest totaling 2,940,000 shares, a decline of 16.7% from the October 31st total of 3,530,000 shares. Based on an average daily trading volume, of 983,900 shares, the short-interest ratio is currently 3.0 days. Currently, 4.1% of the shares of the stock are sold short.
View Align Technology's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, February 7th 2024.
View our ALGN earnings forecast.

Align Technology, Inc. (NASDAQ:ALGN) announced its quarterly earnings data on Wednesday, October, 25th. The medical equipment provider reported $1.62 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.86 by $0.24. The medical equipment provider had revenue of $960.21 million for the quarter, compared to analyst estimates of $994.60 million. Align Technology had a trailing twelve-month return on equity of 12.66% and a net margin of 9.53%.

ETFs with the largest weight of Align Technology (NASDAQ:ALGN) stock in their portfolio include First Trust Nasdaq Lux Digital Health Solutions ETF (EKG), Guru Favorite Stocks ETF (GFGF), Roundhill S&P Dividend Monarchs ETF (KNGS), BNY Mellon Innovators ETF (BKIV), BlackRock Future Health ETF (BMED), AI Quality Growth ETF (AQGX), First Trust Indxx Medical Devices ETF (MDEV) and Hartford Large Cap Growth ETF (HFGO).

346 employees have rated Align Technology Chief Executive Officer Joe Hogan on Glassdoor.com. Joe Hogan has an approval rating of 97% among the company's employees. This puts Joe Hogan in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Align Technology investors own include NVIDIA (NVDA), Netflix (NFLX), Alibaba Group (BABA), PayPal (PYPL), Micron Technology (MU), Adobe (ADBE), Visa (V), Salesforce (CRM), Mastercard (MA) and Tesla (TSLA).

Align Technology's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Polen Capital Management LLC (2.02%), Sands Capital Management LLC (2.00%), Bank of New York Mellon Corp (1.61%), Brown Advisory Inc. (1.39%), Morgan Stanley (1.33%) and Rhenman & Partners Asset Management AB (1.31%). Insiders that own company stock include C Raymond Larkin Jr, C Raymond Larkin, Jr, Emory Wright, George J Morrow, John Morici, Joseph M Hogan, Julie Ann Coletti, Kevin C Burns, Kevin J Dallas, Robert E Fitzgerald, Stuart A Hockridge, Thomas M Prescott and Warren S Thaler.
View institutional ownership trends.

Shares of ALGN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.